Prebiotics and probiotics: Are they functional foods?

American Journal of Clinical Nutrition

Volumn 71, Issue 6 SUPPL., 2000, Pages

  Roberfroid, Marcel B ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Bifidobacteria; Inulin; Lactobacilli; Prebiotic; Probiotic; Synbiotic

Indexed keywords

YOGHURT;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIET SUPPLEMENTATION; DYSLIPIDEMIA; FREEZE DRYING; IMMUNE RESPONSE; INSULIN RESISTANCE; LACTOSE INTOLERANCE; OSTEOPOROSIS; RISK FACTOR; ROTAVIRUS;

EID: 0034045571     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/71.6.1682s     Document Type: Conference Paper

References (48)

1. Salminen S, Bouley C, Boutron-Ruault MC, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998;80(suppl):S147-71.
2. Gibson GR, Roberfroid MB. Dietary modulation of the human colonie microflora: introducing the concept of prebiotics. J Nutr 1995;125:1401-12.
3. Roberfroid MB. Concepts and strategy of functional food science: the European perspective. Am J Clin Nutr 2000;71 (suppl): 1660S-4S.
4. Bellisle F, Diplock AT, Hornstra G, et al. Functional food science in Europe. Br J Nutr 1998;80(suppl):S3-4.
5. Clydesdale F. A proposal for the establishment of scientific criteria for health claims for functional foods. Nutr Rev 1997;55:413-22.
6. Roberfroid MB. Functional effects of food components and the gastrointestinal system: chicory fructooligosaccharides. Nutr Rev 1996;54:S38-42.
7. Sanders ME. Summary of the conclusions from a consensus panel of experts on health attributes on lactic cultures: significance to fluid milk products containing cultures. J Diary Sci 1993;76:1819-28.
8. Marteau P, Rambaud JC. Potential for using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol Rev 1993;12:207-20.
9. Salminen S, Isolauri E, Salminen E. Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek 1996;70:347-58.
10. Mortomi M. Properties of Lactobacillus casei Shirota strains as probiotics. Asia Pac J Clin Nutr 1996;5:29-30.
11. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992;32:141(4.
12. Schiffrin E, Rochat F, Link-Amster H, et al. Immunomodulation of blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995;78:491-7.
13. Jackson TG, Taylor GRJ, Clohessy AM, et al. The effects of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br J Nutr 1999;89:23-30.
14. Reddy BS, Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary and liver carcinogenesis induced by 2-amino-3 methylimidazol[4,5-f]quinoline, a food mutagen. Cancer Res 1993; 53:3914-8.
15. Roberfroid MB, Delzenne N. Dietary fructans. Annu Rev Nutr 1998;18:117-43.
16. Roberfroid MB, Van Loo JAE, Gibson GR. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 1998;128:11-9.
17. Hoebregs H. Fructans in foods and food products, ion-exchange chromatographic method: collaborative study. J Assoc Off Anal Chem Int 1997;80:1029-37.
18. Van Loo J, Coussement P, De Leenheer L, et al. On the presence of inulin and oligofructose as natural ingredients in the Western diet. Crit Rev Food Sci Nutr 1995;35:525-52.
19. Cummings JH, Roberfroid MB. A new look at dietary carbohydrate: chemistry, physiology and health. Eur J Clin Nutr 1997;51:417-42.
20. Ellegärd L, Andersson H, Bosaeus I. Inulin and oligofructose do not influence the absorption of cholesterol or the excretion of cholesterol, Ca, Mg, Zn, Fe, or bile acids but increases energy excretion in ileostomy subjects. Eur J Clin Nutr 1997;51:1-5.
21. Coudray C, Bellanger J, Catiglia-Delavaud C, et al. Effect of soluble and partly soluble dietary fibres supplementation on absorption and balance of calcium, magnesium, iron and zinc in healthy young men. Eur J Clin Nutr 1997;51:375-80.
22. van den Heuvel EGHM, Muys T, Van Dokkum W, et al. Oligofructose stimulates calcium absorption in adolescents. Am J Clin Nutr 1999;69:544-8.
23. Fiordaliso M, Kok N, Desager JP, et al. Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats. Lipids 1995;30:163(7.
24. Takase S, Goda T, Watanabe M. Monostearylglycerol-starch complex: its digestibility and effects on glycemic and lipogenic responses. J Nutr 1994;40:23-36.
25. Davidson MH, Maki KC, Synecki C, et al. Evaluation of the influence of dietary inulin on serum lipids in adults with hypercholesterolemia. Nutrition 1998;18:503-17.
26. Reddy DS, Hamid R, Rao CV. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 1997;18:1371-4.
27. Rowland IR, Rumney CJ, Coutts JT, Lievense LC. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced crypt foci in rats. Carcinogenesis 1997;19: 281-5.
28. Salminen S, Bouley CH, Boutro-Ruault MC, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998;80(suppl):S147-71.
29. Naidu AS, Bidlack WR, Clemens RA. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr 1999;38:13-126.
30. Tannock GW. Probiotics: a critical review. Wymondham, UK: Horizon Scientific Press, 1999.
31. Van Loo J, Cummings J, Delzenne N, et al. Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO projects (DGXII IRII-CT94-1095). Br J Nutr 1999;81: 121-32.
32. Milner JA, Roberfroid M. Nutritional properties of inulin and oligofructose. J Nutr 1999;129:S1395-502.
33. Marteau P, Vesa T, Rambaud JC. Lactose malabsorption. In: Fuller R, ed. Probiotics 2: applications and practical aspects London: Chapman & Hall, 1997:65-88.
34. Goldin BR. Health benefits of probiotics. Br J Nutr 1998;80 (suppl):S203-7.
35. Famularo G, Moretti S, Marcellini S, DeSimone C. Stimulation of immunity by probiotics. In: Fuller R, ed. Probiotics 2: applications and practical aspects. London: Chapman & Hall, 1997:133-61.
36. Hosono A, Kitazawa H, Yamaguchi T. Antimutagenicity and antitumor activities of lactic acid bacteria. In Fuller R, ed. Probiotics 2: applications and practical aspects. London: Chapman & Hall, 1997:89-132.
37. Taylor GRJ, Williams CM. Effect of probiotics and prebiotics on blood lipids. Br J Nutr 1998;80(suppl):S225-30.
38. Canzi E, Brighenti F, Casighari MC, et al. Prolonged consumption of inulin in ready-to-eat breakfast cereals: effects on intestinal ecosystem, bowel habits and lipid metabolism. EU-Cost 92, Workshop on Dietary Fiber and Fermentation in the Colon. Helsiniki: Luxembourg Office for Official Publications of the European Communities, 1995:280-4.
39. Delzenne NM, Kok NN. Biochemical basis of oligofructose-induced hypolipidemia in animal models. J Nutr 1999;129(suppl):S1467-70.
40. Gibson GR, Saavedra JM, MacFarlane S, MacFarlane GT. Probiotics and intestinal flora. In: Fuller R, ed. Probiotics 2: applications and practical aspects. London: Chapman & Hall, 1997:10-39.
41. Corthier G. Antibiotic-associated diarrhoea and pseudomembranous colitis. In: Fuller R, ed. Probiotics 2: applications and practical aspects. London: Chapman & Hall, 1997:40-64.
42. Isolauri E, Juntunen M, Rautanen T, et al. A human Lactobacillus strain (Lactobacillus casei strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88:90-7.
43. Saavedra JM, Bauman NA, Oung I, et al. Feeding Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994; 344:1046-9.
44. Reddy BS. Prevention of colon cancer by pre- and probiotics: evidence from laboratory studies. Br J Nutr 1998;80(suppl):S219-23.
45. Gibson GR, Beatty EB, Wang X. Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995;108:975-82.
46. Cummings JH. The large intestine in nutrition and disease. Danone Chair Monograph 1997. Brussels: Institut Danone, 1997.
47. Reddy BS. Possible mechanisms by which pro-and prebiotics influence colon carcinogenesis and tumor growth. J Nutr 1999; 129(suppl):S1478-82.
48. Roberfroid MB, Gibson GR, Delzenne N. Biochemistry of oligofructose, a non-digestible fructo-oligosaccharide: an approach to estimate its caloric value. Nutr Rev 1993;51:137-46.